Dyadic Announces Nonexclusive Research License with WuXi Biologics
March 30, 2020JUPITER, FL / ACCESSWIRE / March 30, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and …